139 related articles for article (PubMed ID: 28335578)
1. Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells.
Li Z; Guo JR; Chen QQ; Wang CY; Zhang WJ; Yao MC; Zhang W
Molecules; 2017 Mar; 22(3):. PubMed ID: 28335578
[TBL] [Abstract][Full Text] [Related]
2. Biochemical modulation of Ara-C effects by amidox, an inhibitor of ribonucleotide reductase in HL-60 promyelocytic human leukemia cells.
Höchtl T; Horvath Z; Bauer W; Karl D; Saiko P; Elford HL; Fritzer-Szekeres M; Szekeres T
Life Sci; 2004 Jan; 74(9):1071-80. PubMed ID: 14687648
[TBL] [Abstract][Full Text] [Related]
3. Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein.
Bullock G; Ray S; Reed JC; Krajewski S; Ibrado AM; Huang Y; Bhalla K
Leukemia; 1996 Nov; 10(11):1731-40. PubMed ID: 8892676
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Nrf2-mediated glucose metabolism by brusatol synergistically sensitizes acute myeloid leukemia to Ara-C.
Cheng C; Yuan F; Chen XP; Zhang W; Zhao XL; Jiang ZP; Zhou HH; Zhou G; Cao S
Biomed Pharmacother; 2021 Oct; 142():111652. PubMed ID: 34112534
[TBL] [Abstract][Full Text] [Related]
5. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
6. Effect of cytarabine and decitabine in combination in human leukemic cell lines.
Qin T; Youssef EM; Jelinek J; Chen R; Yang AS; Garcia-Manero G; Issa JP
Clin Cancer Res; 2007 Jul; 13(14):4225-32. PubMed ID: 17634552
[TBL] [Abstract][Full Text] [Related]
7. Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.
Fritzer-Szekeres M; Salamon A; Grusch M; Horvath Z; Höchtl T; Steinbrugger R; Jäger W; Krupitza G; Elford HL; Szekeres T
Biochem Pharmacol; 2002 Aug; 64(3):481-5. PubMed ID: 12147300
[TBL] [Abstract][Full Text] [Related]
8. Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cells.
Chen P; Aimiuwu J; Xie Z; Wei X; Liu S; Klisovic R; Marcucci G; Chan KK
AAPS J; 2011 Mar; 13(1):131-40. PubMed ID: 21191677
[TBL] [Abstract][Full Text] [Related]
9. Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells.
Song JH; Kim SH; Kweon SH; Lee TH; Kim HJ; Kim HJ; Kim TS
Int J Oncol; 2009 Apr; 34(4):1165-71. PubMed ID: 19287976
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells.
Horvath Z; Murias M; Saiko P; Erker T; Handler N; Madlener S; Jaeger W; Grusch M; Fritzer-Szekeres M; Krupitza G; Szekeres T
Exp Hematol; 2006 Oct; 34(10):1377-84. PubMed ID: 16982330
[TBL] [Abstract][Full Text] [Related]
11. Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
Horvath Z; Saiko P; Illmer C; Madlener S; Hoechtl T; Bauer W; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
Exp Hematol; 2005 Mar; 33(3):329-35. PubMed ID: 15730856
[TBL] [Abstract][Full Text] [Related]
12. [The negative effect of 4-methylhistamine, an H2 receptor agonist, on cytotoxicity of Ara-C for HL-60 leukemia cells].
He Q; Xu YH
Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):1-5. PubMed ID: 12212232
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
Nandy P; Lien EJ; Avramis VI
Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
[TBL] [Abstract][Full Text] [Related]
14. Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells.
Bauer W; Horvath Z; Höchtl T; Saiko P; Karl D; Fritzer-Szekeres M; Szekeres T
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1541-4. PubMed ID: 15571294
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines.
Kanno S; Higurashi A; Watanabe Y; Shouji A; Asou K; Ishikawa M
Toxicol Lett; 2004 Sep; 152(2):149-58. PubMed ID: 15302096
[TBL] [Abstract][Full Text] [Related]
16. [Ara-c induced apoptosis in human myeloid leukemia cell line HL-60].
Zhou J; Chen Y; Li C
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):107-10. PubMed ID: 10743072
[TBL] [Abstract][Full Text] [Related]
17. A Novel cytarabine analog evokes synthetic lethality by targeting MK2 in p53-deficient cancer cells.
Song J; Yu J; Jeong LS; Lee SK
Cancer Lett; 2021 Jan; 497():54-65. PubMed ID: 33075425
[TBL] [Abstract][Full Text] [Related]
18. Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C.
Fritzer-Szekeres M; Savinc I; Horvath Z; Saiko P; Pemberger M; Graser G; Bernhaus A; Ozsvar-Kozma M; Grusch M; Jaeger W; Szekeres T
Int J Oncol; 2008 Oct; 33(4):887-92. PubMed ID: 18813804
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of 1-beta-D-arabinofuranosylcytosine (Ara-C) cytotoxicity in leukaemia cells by co-administration with antisignalling drugs.
Freund A; Boos J; Harkin S; Schultze-Mosgau M; Veerman G; Peters GJ; Gescher A
Eur J Cancer; 1998 May; 34(6):895-901. PubMed ID: 9797704
[TBL] [Abstract][Full Text] [Related]
20. SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
Schneider C; Oellerich T; Baldauf HM; Schwarz SM; Thomas D; Flick R; Bohnenberger H; Kaderali L; Stegmann L; Cremer A; Martin M; Lohmeyer J; Michaelis M; Hornung V; Schliemann C; Berdel WE; Hartmann W; Wardelmann E; Comoglio F; Hansmann ML; Yakunin AF; Geisslinger G; Ströbel P; Ferreirós N; Serve H; Keppler OT; Cinatl J
Nat Med; 2017 Feb; 23(2):250-255. PubMed ID: 27991919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
